184 related articles for article (PubMed ID: 27224576)
1. Dual-Energy Perfusion-CT in Recurrent Pancreatic Cancer - Preliminary Results.
Fritz F; Skornitzke S; Hackert T; Kauczor HU; Stiller W; Grenacher L; Klauss M
Rofo; 2016 Jun; 188(6):559-65. PubMed ID: 27224576
[TBL] [Abstract][Full Text] [Related]
2. Dual-energy perfusion-CT of pancreatic adenocarcinoma.
Klauss M; Stiller W; Pahn G; Fritz F; Kieser M; Werner J; Kauczor HU; Grenacher L
Eur J Radiol; 2013 Feb; 82(2):208-14. PubMed ID: 23062281
[TBL] [Abstract][Full Text] [Related]
3. Computed tomography perfusion analysis of pancreatic carcinoma.
Klauss M; Stiller W; Fritz F; Kieser M; Werner J; Kauczor HU; Grenacher L
J Comput Assist Tomogr; 2012; 36(2):237-42. PubMed ID: 22446366
[TBL] [Abstract][Full Text] [Related]
4. Iodine concentration and tissue attenuation in dual-energy contrast-enhanced CT as a potential quantitative parameter in early detection of local pancreatic carcinoma recurrence after surgical resection.
Mathy RM; Fritz F; Mayer P; Klauss M; Grenacher L; Stiller W; Kauczor HU; Skornitzke S
Eur J Radiol; 2021 Oct; 143():109944. PubMed ID: 34482176
[TBL] [Abstract][Full Text] [Related]
5. Imaging findings of recurrent pancreatic cancer following resection.
Javadi S; Karbasian N; Bhosale P; de Castro Faria S; Le O; Katz MH; Koay EJ; Tamm EP
Abdom Radiol (NY); 2018 Feb; 43(2):489-496. PubMed ID: 29198001
[TBL] [Abstract][Full Text] [Related]
6. Correlation of quantitative dual-energy computed tomography iodine maps and abdominal computed tomography perfusion measurements: are single-acquisition dual-energy computed tomography iodine maps more than a reduced-dose surrogate of conventional computed tomography perfusion?
Stiller W; Skornitzke S; Fritz F; Klauss M; Hansen J; Pahn G; Grenacher L; Kauczor HU
Invest Radiol; 2015 Oct; 50(10):703-8. PubMed ID: 26039774
[TBL] [Abstract][Full Text] [Related]
7. Role of rapid kV-switching dual-energy CT in assessment of post-surgical local recurrence of pancreatic adenocarcinoma.
Parakh A; Patino M; Muenzel D; Kambadakone A; Sahani DV
Abdom Radiol (NY); 2018 Feb; 43(2):497-504. PubMed ID: 29138890
[TBL] [Abstract][Full Text] [Related]
8. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
9. Vascularity and Tumor Size are Significant Predictors for Recurrence after Resection of a Pancreatic Neuroendocrine Tumor.
Yamamoto Y; Okamura Y; Uemura S; Sugiura T; Ito T; Ashida R; Kato Y; Ohgi K; Yamada M; Sasaki K; Aramaki T; Uesaka K
Ann Surg Oncol; 2017 Aug; 24(8):2363-2370. PubMed ID: 28271173
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors.
d'Assignies G; Couvelard A; Bahrami S; Vullierme MP; Hammel P; Hentic O; Sauvanet A; Bedossa P; Ruszniewski P; Vilgrain V
Radiology; 2009 Feb; 250(2):407-16. PubMed ID: 19095784
[TBL] [Abstract][Full Text] [Related]
11. CT imaging of early local recurrence of pancreatic adenocarcinoma following pancreaticoduodenectomy.
Balaj C; Ayav A; Oliver A; Jausset F; Sellal C; Claudon M; Laurent V
Abdom Radiol (NY); 2016 Feb; 41(2):273-82. PubMed ID: 26867909
[TBL] [Abstract][Full Text] [Related]
12. Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence.
Asagi A; Ohta K; Nasu J; Tanada M; Nadano S; Nishimura R; Teramoto N; Yamamoto K; Inoue T; Iguchi H
Pancreas; 2013 Jan; 42(1):11-9. PubMed ID: 22699206
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhancement ratio on multiphase enhanced computed tomography predicts recurrence of pancreatic neuroendocrine tumor after curative resection.
Arai T; Kobayashi A; Fujinaga Y; Yokoyama T; Shimizu A; Motoyama H; Kitagawa N; Notake T; Shirota T; Fukushima K; Masuo H; Kadoya M; Miyagawa S
Pancreatology; 2016; 16(3):397-402. PubMed ID: 26850565
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of multi-detector computed tomography, fluorodeoxyglucose positron emission tomography-CT, and CA 19-9 levels in detecting recurrent pancreatic adenocarcinoma.
Hamidian Jahromi A; Sangster G; Zibari G; Martin B; Chu Q; Takalkar A; Shi R; Shokouh-Amiri H
JOP; 2013 Jul; 14(4):466-8. PubMed ID: 23846950
[TBL] [Abstract][Full Text] [Related]
15. Intraductal papillary mucinous neoplasms of the pancreas: CT patterns of recurrence and multiobserver performance in detecting recurrent neoplasm after surgical resection.
Christensen JA; Fletcher JG; Fidler JL; Wold PB; Binstock AJ; Smyrk T; Harmsen SW; Crownhart BS; Chari S
AJR Am J Roentgenol; 2004 Nov; 183(5):1367-74. PubMed ID: 15505305
[TBL] [Abstract][Full Text] [Related]
16. Qualitative and quantitative evaluation of rigid and deformable motion correction algorithms using dual-energy CT images in view of application to CT perfusion measurements in abdominal organs affected by breathing motion.
Skornitzke S; Fritz F; Klauss M; Pahn G; Hansen J; Hirsch J; Grenacher L; Kauczor HU; Stiller W
Br J Radiol; 2015 Feb; 88(1046):20140683. PubMed ID: 25465353
[TBL] [Abstract][Full Text] [Related]
17. Role of CT perfusion imaging in patients with variously differentiated gastric adenocarcinoma.
Sun ZQ; Cheng XF; Ge YX; Chen L; Yue JG; Jin LF; Xie ZH; Zhang HD; Xuan YH
J Xray Sci Technol; 2015; 23(6):737-44. PubMed ID: 26756409
[TBL] [Abstract][Full Text] [Related]
18. Dual-energy CT iodine maps as an alternative quantitative imaging biomarker to abdominal CT perfusion: determination of appropriate trigger delays for acquisition using bolus tracking.
Skornitzke S; Fritz F; Mayer P; Koell M; Hansen J; Pahn G; Hackert T; Kauczor HU; Stiller W
Br J Radiol; 2018 May; 91(1085):20170351. PubMed ID: 29446319
[TBL] [Abstract][Full Text] [Related]
19. EUS-guided FNA of local recurrence of pancreatic cancer after surgical resection.
DeWitt J; Sherman S; Al-Haddad M; McHenry L; Cote GA; Leblanc JK
Gastrointest Endosc; 2010 Nov; 72(5):1076-80. PubMed ID: 20869713
[TBL] [Abstract][Full Text] [Related]
20. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
